ALDH1A1 and non-small cell lung carcinoma: This study set out to investigate the potential exploitation of the CSC marker, ALDH1, and its role in the metabolism of vitamin A and subsequent conversion to retinoic acid in cisplatin-resistant NSCLC, and to further explore the differentiation potential of retinoic acid in relation to CSCs and CSC-mediated mechanisms of resistance.